大和:重申互太紡織(1382.HK)買入評級 目標價升至5.95港元
大和發表研究報吿表示,將互太紡織(1382.HK)目標價由5港元升至5.95港元,重申買入評級,並表示9%股息收益率有吸引力和增長前景改善,但同時將2022-23年的每股盈利預測下調9-12%,由於原材料價格壓力,將較低的利潤率預測考慮在內。
報吿指,2021財年艱難,去年淨利潤下降3%至7.21億元,低於市場預期。業績較預期差主要是由於銷售組合轉向更低平均單價產品,加上需求疲軟和原材料成本價格受壓。
該行指,最艱難的時期可能已經過去,預計2022財年的增長前景將有所改善,行業成本上漲,客户已接受。鑑於需求強勁復甦,公司將更加專注於高端產品,預計明年下半年毛利率復甦。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.